Mature cystic fibrosis airway neutrophils suppress T cell function: evidence for a role of arginase 1 but not programmed death-ligand 1.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 25926674)

Published in J Immunol on April 29, 2015

Authors

Sarah A Ingersoll1, Julie Laval1, Osric A Forrest1, Marcela Preininger1, Milton R Brown1, Dalia Arafat2, Greg Gibson2, Vin Tangpricha3, Rabindra Tirouvanziam4

Author Affiliations

1: Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322; Center for Cystic Fibrosis and Airways Disease Research, Children's Healthcare of Atlanta, Atlanta, GA 30322;
2: Center for Integrative Genomics, School of Biology, Georgia Institute of Technology, Atlanta, GA 30313; and.
3: Department of Medicine, Emory University School of Medicine, Atlanta, GA 30322.
4: Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322; Center for Cystic Fibrosis and Airways Disease Research, Children's Healthcare of Atlanta, Atlanta, GA 30322; tirouvanziam@emory.edu.

Articles cited by this

PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol (2008) 19.24

T cell exhaustion. Nat Immunol (2011) 11.08

Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity (2007) 8.94

Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients. Cancer Res (2001) 4.49

Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells. J Immunol (1999) 3.68

Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity. Blood (2004) 2.61

A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J Clin Invest (2011) 2.52

Interleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease. Annu Rev Immunol (2013) 2.47

TCR zeta-chain downregulation: curtailing an excessive inflammatory immune response. Nat Rev Immunol (2004) 2.11

Cystic fibrosis: a mucosal immunodeficiency syndrome. Nat Med (2012) 2.03

Sputum biomarkers of inflammation and lung function decline in children with cystic fibrosis. Am J Respir Crit Care Med (2012) 2.01

Decreased arginine bioavailability and increased serum arginase activity in asthma. Am J Respir Crit Care Med (2004) 2.01

Cell surface-bound elastase and cathepsin G on human neutrophils: a novel, non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteinases. J Cell Biol (1995) 1.98

The multifaceted functions of neutrophils. Annu Rev Pathol (2013) 1.97

Suppression of T-cell functions by human granulocyte arginase. Blood (2006) 1.85

Control of immune response by amino acid metabolism. Immunol Rev (2010) 1.63

Neutrophils in cystic fibrosis. Thorax (2009) 1.51

L-Arginine modulates CD3zeta expression and T cell function in activated human T lymphocytes. Cell Immunol (2005) 1.45

The immune response to chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients is predominantly of the Th2 type. APMIS (2000) 1.33

Oxidation of cofilin mediates T cell hyporesponsiveness under oxidative stress conditions. Immunity (2008) 1.32

Quantitative analysis of inflammatory cells infiltrating the cystic fibrosis airway mucosa. Clin Exp Immunol (2001) 1.32

Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences. Cell Mol Life Sci (2013) 1.26

Arginase 1 is expressed in myelocytes/metamyelocytes and localized in gelatinase granules of human neutrophils. Blood (2007) 1.26

Arginase I expression and activity in human mononuclear cells after injury. Ann Surg (2001) 1.25

Increased arginase activity in cystic fibrosis airways. Am J Respir Crit Care Med (2005) 1.21

Immune suppression by neutrophils in HIV-1 infection: role of PD-L1/PD-1 pathway. PLoS Pathog (2014) 1.15

Flagellin induces myeloid-derived suppressor cells: implications for Pseudomonas aeruginosa infection in cystic fibrosis lung disease. J Immunol (2012) 1.15

Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways. Proc Natl Acad Sci U S A (2008) 1.13

Alveolar inflammation in cystic fibrosis. J Cyst Fibros (2010) 1.11

Activation of critical, host-induced, metabolic and stress pathways marks neutrophil entry into cystic fibrosis lungs. Proc Natl Acad Sci U S A (2009) 1.08

Exocytosis of azurophil and arginase 1-containing granules by activated polymorphonuclear neutrophils is required to inhibit T lymphocyte proliferation. J Leukoc Biol (2011) 1.07

Characterization of macrophage activation states in patients with cystic fibrosis. J Cyst Fibros (2010) 1.07

Surface expression of Fc gamma receptor III (CD16) on chemoattractant-stimulated neutrophils is determined by both surface shedding and translocation from intracellular storage compartments. J Clin Invest (1992) 1.06

Inhaled L-arginine improves exhaled nitric oxide and pulmonary function in patients with cystic fibrosis. Am J Respir Crit Care Med (2006) 1.05

The dual role of neutrophil elastase in lung destruction and repair. Int J Biochem Cell Biol (2007) 1.01

Patients with cystic fibrosis have inducible IL-17+IL-22+ memory cells in lung draining lymph nodes. J Allergy Clin Immunol (2012) 1.00

Active systemic lupus erythematosus is associated with failure of antigen-presenting cells to express programmed death ligand-1. Rheumatology (Oxford) (2008) 0.99

Programmed death ligand 1 is over-expressed by neutrophils in the blood of patients with active tuberculosis. Eur J Immunol (2011) 0.97

A randomized controlled trial of inhaled L-arginine in patients with cystic fibrosis. J Cyst Fibros (2013) 0.97

Distinct patterns of inflammation in the airway lumen and bronchial mucosa of children with cystic fibrosis. Thorax (2011) 0.96

Development of a sandwich ELISA for evaluating soluble PD-L1 (CD274) in human sera of different ages as well as supernatants of PD-L1+ cell lines. Cytokine (2011) 0.96

Cleavage of lymphocyte surface antigens CD2, CD4, and CD8 by polymorphonuclear leukocyte elastase and cathepsin G in patients with cystic fibrosis. J Immunol (1995) 0.96

Selective proteolytic cleavage of IL-2 receptor and IL-6 receptor ligand binding chains by neutrophil-derived serine proteases at foci of inflammation. J Interferon Cytokine Res (1999) 0.94

Therapeutics development for cystic fibrosis: a successful model for a multisystem genetic disease. Annu Rev Med (2011) 0.94

Using blood informative transcripts in geographical genomics: impact of lifestyle on gene expression in fijians. Front Genet (2012) 0.94

Neutrophils and T cells: bidirectional effects and functional interferences. Mol Immunol (2011) 0.94

Metabolic adaptation of neutrophils in cystic fibrosis airways involves distinct shifts in nutrient transporter expression. J Immunol (2013) 0.89

Nitric oxide and L-arginine deficiency in cystic fibrosis. Curr Pharm Des (2012) 0.89

Elastase and metalloproteinase activities regulate soluble complement receptor 1 release. Eur J Immunol (1999) 0.88

Lung arginase expression and activity is increased in cystic fibrosis mouse models. J Appl Physiol (1985) (2014) 0.79